Several studies have demonstrated that breast cancer and others cell lines like ovarian cancer cells produce autocrine PRL, and that the incubation with PRL antibodies and other PRLR antagonists reduce the cell number[42-44]. Here, PRLR is linked to ovarian carcinoma.